As of November 6, 2026, Generate Biomedicines, Inc. is a publicly traded company (Nasdaq: GENB); its largest reported holder is Flagship Pioneering, LLC, with 48.9% on Schedule 13G of May 15, 2026, then Fidelity (FMR) (5.6%) (Schedule 13G, May 15, 2026).
Is this your company?
About to sign with, pay or invest in Generate Biomedicines, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Generate Biomedicines, Inc. a real, registered company?
- Generate Biomedicines, Inc. files with the SEC under CIK 2100782 (its SEC filings).
- Its shares are listed under the ticker GENB on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Somerville, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under GENERATE BIOMEDICINE INC in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Fidelity (FMR) (filed 2026-11-05).
Who are Generate Biomedicines, Inc.'s owners and officers?
Generate Biomedicines, Inc.: incorporated in Delaware; business address in Somerville, Massachusetts; industry Pharmaceutical Preparations (Schedule 13G, 2026-11-05).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-11-05 | Fmr LLC | 5.6% |
| Schedule 13G, 2026-05-15 | Flagship Pioneering, LLC | 48.9% |
| Schedule 13G, 2026-05-15 | Nally Michael | 5.2% |
Questions about who owns Generate Biomedicines, Inc.
Who owns Generate Biomedicines, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Generate Biomedicines, Inc.: Flagship Pioneering, LLC (48.9%, Schedule 13G, filed 2026-05-15), Fmr LLC (5.6%, Schedule 13G, filed 2026-11-05) and Nally Michael (5.2%, Schedule 13G, filed 2026-05-15).
Who are the largest shareholders of Generate Biomedicines, Inc.?
By the share each holder's latest filing reports, the largest holders of Generate Biomedicines, Inc. on this page are Flagship Pioneering, LLC (48.9%), Fmr LLC (5.6%) and Nally Michael (5.2%).
When did Flagship Pioneering, LLC buy into Generate Biomedicines, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Flagship Pioneering, LLC on this page is the Schedule 13G, filed 2026-05-15, reporting 48.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 3 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Generate Biomedicines, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Generate Biomedicines, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Generate Biomedicines, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Generate Biomedicines, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , L.P., a 10% owner: 62,673,117 shares (48.8% of shares outstanding), held indirectly through By Flagship Pioneering Fund VI, L.P. and 2 others, on a joint filing (Form 4, 2026-03-02).
- Nutritional Health LTP Fund, L.P., a 10% owner: 62,673,117 shares (48.8% of shares outstanding), held indirectly through By Flagship Pioneering Fund VI, L.P. and 2 others, on a joint filing (Form 4, 2026-03-02).
- , a director and 10% owner: 62,673,117 shares (48.8% of shares outstanding), held indirectly through By Nutritional Health LTP Fund, L.P. and 2 others, on a joint filing (Form 4, 2026-03-02).
- Flagship Pioneering Special Opportunities Fund II, L.P., a 10% owner: 62,673,117 shares (48.8% of shares outstanding), held indirectly through By Flagship Pioneering Fund VI, L.P. and 2 others, on a joint filing (Form 4, 2026-03-02).
- Flagship VentureLabs VI LLC, a 10% owner: 62,673,117 shares (48.8% of shares outstanding), held indirectly through By Flagship Pioneering Fund VI, L.P. and 2 others, on a joint filing (Form 4, 2026-03-02).
Shares outstanding: 128,352,436 as of 2026-07-29, from the company's latest SEC cover page.
How much has Generate Biomedicines, Inc. raised?
Latest IPO step: Generate Biomedicines, Inc. filed its final IPO prospectus, ticker GENB (424B4, 2026-02-27).
IPO filings: 424B4, 2026-02-27, S-1/A, 2026-02-23, S-1/A, 2026-02-13, S-1, 2026-02-04; ticker GENB on Nasdaq Global Select Market.
Keep reading
More on Generate Biomedicines, Inc. and the records around it.
Generate Biomedicines, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
Companies that share a holder
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/generate-biomedicine